the present invention relates to generally to pharmaceutical formulations . particularly , the present invention relates to a drug nanocarrier that is stabilized by lipids , preferably lecithins and / or lipid - terminated polyalkylene glycol , for the delivery of poorly soluble drugs with high drug loading and its utility in the fields of pharmaceutical formulation , drug delivery , medicine and diagnosis .